How much does the Turkish version of Valganciclovir cost? Comparison with original drug

Valganciclovir is a prescription drug widely used in the treatment of viral diseases. Its core mechanism is to inhibit the DNA synthesis of cytomegalovirus (CMV), thereby blocking the replication and spread of the virus. This drug was first developed by Roche Pharmaceuticals and launched into the global market. It is currently one of the important choices for the treatment of cytomegalovirus infection in the world.

In terms of indications, valganciclovir is approved for use in two typical groups of people: one is for patients receiving organ transplants to prevent CMV infection caused by immunosuppression; the other is for the treatment of cytomegalovirus retinitis in AIDS patients to reduce the risk of vision loss. With the accumulation of clinical experience, the preventive application of this drug in some high-risk groups has gradually been recognized.

In terms of price, the selling price of the original drug of valganciclovir in Europe, the United States and some Asian countries has remained at a relatively high level. Due to the differentiated pricing policy implemented in Türkiye, drug prices are often lower than those in Western European and North American markets. According to market data, the valganciclovir sold in Turkey is an original drug with a specification of 450mg*60 tablets. The price per box is about RMB 5,000. There is a certain gap compared with the price of the original drug in the domestic market. This is one of the reasons why many patients choose to purchase drugs across the border. It is worth noting that there is no difference in ingredients, dosage, and efficacy between the Turkish version and the original drug. Both are produced by the original factory, ensuring the consistency and safety of the drug. Therefore, the Turkish version is more like a reflection of the pricing differences of the same original drug in different national markets.

Since valganciclovir often requires long-term use, the price difference will directly affect patient compliance. In overseas markets, in addition to original drugs, some generic drugs have also been launched, providing patients with more flexible choices.

Reference materials:https://go.drugbank.com/drugs/DB01610